Cannabidiol Market Analysis and Forecast to 2031: By Product Type (Oil, Capsules, Cream, Suppositories, Gum, Others), Source Type (Marijuana, Hemp), Sales Type (B2B, B2C), End-use (Medical, Personal Use, Pharmaceuticals, Wellness), and Region
Cannabidiol (CBD) is a chemical compound that is found in the cannabis sativa plant, and is extracted from hemp or cannabis, generally from hemp due to its naturally high cannabidiol (CBD) content. It has several benefits in treating anxiety and seizures and reducing pain. Due to its healing properties, the demand for CBD for health and wellness purposes is high, which is the major factor driving the market. Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the global market is anticipated to grow at a lucrative rate over the forecast period. Cannabidiol oil is increasingly being used to make skincare products to treat acne and wrinkles. Sephora, for example, had recently introduced cannabidiol or CBD skincare line to its stores. Similarly, Ulta Beauty is intending to launch a cannabidiol-based product line. Several new companies are also entering the market for cannabidiol-infused cosmetic products.
COVID-19 Impact:
The COVID-19 pandemic has caused unprecedented lockdowns all around the world, collapsing daily operations and changing consumer behaviors in nearly every industry. As the response to COVID-19 ramps up, retail stores have shut down. The market started witnessing a shortage in supply due to the nationwide shutdown of transportation and manufacturing in major raw material manufacturing countries, such as China and India. In addition, due to supply chain disruptions in the U.S., the supply of other raw materials has been limited, which is disrupting the manufacturing, and in turn, the supply chain of CBD consumer health products.
Report Coverage
| Report Attribute | Details |
|---|---|
| Historic Period | 2015-2020 |
| Forecast Period | 2022-2031 |
| Base Year | 2021 |
| Segments Covered | Product Type, Source Type, Sales Type, and End-use |
| Key Companies | Aurora Cannabis Inc. (Canada), Canopy Growth USA, LLC (U.S.), CV Sciences, Inc. (U.S.), Elixinol (U.S.), Endoca BV (Netherlands), Folium Biosciences (U.S.), Isodiol International Inc (U.S.), Medterra CBD, LLC (U.S.), NuLeaf Naturals, LLC (U.S.), and PharmaHemp d.o.o. (Slovenia) |
| Regional Scope | North America, Europe, Asia Pacific, Central & South America, Middle East & Africa |
| Analysis Coverage | Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments |
Key Trends and Drivers:
Rising awareness among consumers regarding health and fitness will help CBD market to witness rapid growth. Increasing consumer disposable income along with the legalization of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in this sector.
Moreover, CBD products are used to relieve various problems such as anxiety/ stress, sleep/insomnia, chronic pain, migraine, skin care, seizures, joint pain & inflammation, neurological conditions, and many others. The chronic pain treatment has gained much popularity due to additional benefits offered by CBD when used. There has been increasing demand for cannabidiol (CBD) products over recent years owing to its widespread medical applications and pain relief treatment. CBD helps in reducing chronic pain by acting on variety of biological process in the body. In addition, CBD possesses antioxidant, anti-inflammatory and analgesic properties. Therefore, CBD products reduces the anxiety that is experienced by the people suffering from the chronic pain. Thus, the increasing demand for CBD in the treatment of chronic pain is augmenting the market to grow. This also help people to maintain their health and fitness routines, while staying away from pain that may occur during fitness activities.
Restraints and Challenges:
CBD is a popular and a holistic choice for people struggling with pain, inflammation, and sleep problems. Since CBD is a new product with less research and development and has lately been regulated and approved, therefore, the price of CBD are subject to fluctuations. The production of hemp became legal in 2018, which affected the price of CBD products. As a result, various CBD products witnessed some price inflation. Moreover, many farmers are transitioning towards growing and selling hemp used to make CBD products, but despite the increased popularity of this product, it presents its own agricultural challenges. Firstly, switching over to a new crop results in new expenses. The most efficient way to harvest hemp is using a combine harvester. However, farmers who have previously grown crops that don’t require combines, such as strawberries, can’t afford to purchase a combine right away. Therefore, they need to hire people to help harvest the hemp, which drives up overall product prices as the raw material becomes costly.
Additionally, hemp requires more time and labor to grow and farmers need to inspect their crop closely as it grows. Furthermore, once it is harvested, extracting the cannabidiol is a difficult and expensive process. The processors and extractors of CBD need to use either ethanol or supercritical carbon dioxide (CO2 extraction). The extraction and refinement process requires special machinery and takes a long time, which drives up the CBD cost. Thus, all these factors add up to the costs of CBD products making them much more costly than other products, which is likely to restrain the market’s demand.
Segmentation:
By Product Type
- Oil
- Capsules
- Cream
- Suppositories
- Gum
- Others
By Source Type
- Marijuana
- Hemp
By Sales Type
- B2B
- B2C
By End-use
- Medical
-
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
-
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East
- Africa
Key Players:
- Aurora Cannabis Inc. (Canada)
- Canopy Growth USA, LLC (U.S.)
- CV Sciences, Inc. (U.S.)
- Elixinol (U.S.)
- Endoca BV (Netherlands)
- Folium Biosciences (U.S.)
- Isodiol International Inc (U.S.)
- Medterra CBD, LLC (U.S.)
- NuLeaf Naturals, LLC (U.S.)
- PharmaHemp d.o.o. (Slovenia)
Recent Developments:
March 31 2022: The Food Standards Agency (FSA) has created a list of more than 3,500 food products infused with cannabidiol (CBD), bringing them one step closer to being authorised as part of government plans to wrest control over a flourishing industry.
March 24 2022: Incannex Healthcare (ASX: IHL) has announced it will acquire APIRx Pharmaceuticals USA in an all scrip (share consideration) deal to affirm its position as a global leader in the fields of cannabinoid, psychedelic and combination pharmaceuticals.
March 29 2022: Since the Pandemic, CBD Sales Have Skyrocketed for Many Health Reasons.
Table Of Contents
Chapter 1. Cannabidiol Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Product Type
3.3. Market Attractiveness Analysis, by Source Type
3.4. Market Attractiveness Analysis, by Sales Type
3.5. Market Attractiveness Analysis, by End-use
Chapter 4. Cannabidiol Market Outlook
4.1. Cannabidiol Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.5.1. Raw Material Suppliers
4.5.2. Manufacturers
4.5.3. Wholesalers and/or Retailers
4.6. Impact of COVID-19 on the Cannabidiol Market
4.7. Impact of the Russia and Ukraine War on the Cannabidiol Market
Chapter 5. Cannabidiol Market by Product Type
5.1. Market overview
5.2. Oil
5.2.1. Market size and forecast, 2021-2031 (US$ million)
5.2.2. Market size and forecast, by region, 2021-2031 (US$ million)
5.3. Capsules
5.3.1. Market size and forecast, 2021-2031 (US$ million)
5.3.2. Market size and forecast, by region, 2021-2031 (US$ million)
5.4. Cream
5.4.1. Market size and forecast, 2021-2031 (US$ million)
5.4.2. Market size and forecast, by region, 2021-2031 (US$ million)
5.5. Suppositories
5.5.1. Market size and forecast, 2021-2031 (US$ million)
5.5.2. Market size and forecast, by region, 2021-2031 (US$ million)
5.6. Gum
5.6.1. Market size and forecast, 2021-2031 (US$ million)
5.6.2. Market size and forecast, by region, 2021-2031 (US$ million)
5.7. Others
5.7.1. Market size and forecast, 2021-2031 (US$ million)
5.7.2. Market size and forecast, by region, 2021-2031 (US$ million)
Chapter 6. Cannabidiol Market by Source Type
6.1. Market overview
6.2. Marijuana
6.2.1. Market size and forecast, 2021-2031 (US$ million)
6.2.2. Market size and forecast, by region, 2021-2031 (US$ million)
6.3. Hemp
6.3.1. Market size and forecast, 2021-2031 (US$ million)
6.3.2. Market size and forecast, by region, 2021-2031 (US$ million)
Chapter 7. Cannabidiol Market by Sales Type
7.1. Market overview
7.2. B2B
7.2.1. Market size and forecast, 2021-2031 (US$ million)
7.2.2. Market size and forecast, by region, 2021-2031 (US$ million)
7.3. B2C
7.3.1. Market size and forecast, 2021-2031 (US$ million)
7.3.2. Market size and forecast, by region, 2021-2031 (US$ million)
Chapter 8. Cannabidiol Market by End-use
8.1. Market overview
8.2. Medical
8.2.1. Market size and forecast, 2021-2031 (US$ million)
8.2.2. Market size and forecast, by region, 2021-2031 (US$ million)
8.3. Personal Use
8.3.1. Market size and forecast, 2021-2031 (US$ million)
8.3.2. Market size and forecast, by region, 2021-2031 (US$ million)
8.4. Pharmaceuticals
8.4.1. Market size and forecast, 2021-2031 (US$ million)
8.4.2. Market size and forecast, by region, 2021-2031 (US$ million)
8.5. Wellness
8.5.1. Market size and forecast, 2021-2031 (US$ million)
8.5.2. Market size and forecast, by region, 2021-2031 (US$ million)
Chapter 9. Global Cannabidiol Market, by Region
9.1. Overview
9.2. North America
9.2.1. Key market trends and opportunities
9.2.2. North America Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.2.3. North America Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.2.4. North America Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.2.5. North America Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.2.6. North America Cannabidiol market size and forecast by Country, 2021-2031, (US$ million)
9.2.7. The U.S.
9.2.7.1. The U.S. Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.2.7.2. The U.S. Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.2.7.3. The U.S. Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.2.7.4. The U.S. Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.2.8. Canada
9.2.8.1. Canada Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.2.8.2. Canada Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.2.8.3. Canada Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.2.8.4. Canada Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.2.9. Mexico
9.2.9.1. Mexico Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.2.9.2. Mexico Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.2.9.3. Mexico Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.2.9.4. Mexico Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.3. Europe
9.3.1. Key market trends and opportunities
9.3.2. Europe Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.3.3. Europe Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.3.4. Europe Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.3.5. Europe Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.3.6. Europe Cannabidiol market size and forecast by Country, 2021-2031, (US$ million)
9.3.7. Germany
9.3.7.1. Germany Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.3.7.2. Germany Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.3.7.3. Germany Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.3.7.4. Germany Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.3.8. France
9.3.8.1. France Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.3.8.2. France Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.3.8.3. France Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.3.8.4. France Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.3.9. U.K.
9.3.9.1. U.K. Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.3.9.2. U.K. Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.3.9.3. U.K. Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.3.9.4. U.K. Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.3.10. Spain
9.3.10.1. Spain Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.3.10.2. Spain Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.3.10.3. Spain Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.3.10.4. Spain Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.3.11. Italy
9.3.11.1. Italy Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.3.11.2. Italy Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.3.11.3. Italy Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.3.11.4. Italy Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.3.12. Russia
9.3.12.1. Russia Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.3.12.2. Russia Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.3.12.3. Russia Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.3.12.4. Russia Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.3.13. Rest of Europe
9.3.13.1. Rest of Europe Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.3.13.2. Rest of Europe Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.3.13.3. Rest of Europe Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.3.13.4. Rest of Europe Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.4. Asia Pacific
9.4.1. Key market trends and opportunities
9.4.2. Asia Pacific Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.4.3. Asia Pacific Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.4.4. Asia Pacific Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.4.5. Asia Pacific Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.4.6. Asia Pacific Cannabidiol market size and forecast by Country, 2021-2031, (US$ million)
9.4.7. China
9.4.7.1. China Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.4.7.2. China Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.4.7.3. China Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.4.7.4. China Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.4.8. India
9.4.8.1. India Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.4.8.2. India Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.4.8.3. India Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.4.8.4. India Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.4.9. Japan
9.4.9.1. Japan Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.4.9.2. Japan Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.4.9.3. Japan Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.4.9.4. Japan Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.4.10. South Korea
9.4.10.1. South Korea Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.4.10.2. South Korea Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.4.10.3. South Korea Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.4.10.4. South Korea Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.4.11. Rest of APAC
9.4.11.1. Rest of APAC Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.4.11.2. Rest of APAC Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.4.11.3. Rest of APAC Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.4.11.4. Rest of APAC Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.5. Rest of the World
9.5.1. Key market trends and opportunities
9.5.2. Rest of the World Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.5.3. Rest of the World Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.5.4. Rest of the World Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.5.5. Rest of the World Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.5.6. Rest of the World Cannabidiol market size and forecast by Country, 2021-2031, (US$ million)
9.5.7. Latin America
9.5.7.1. Latin America Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.5.7.2. Latin America Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.5.7.3. Latin America Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.5.7.4. Latin America Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.5.8. Middle East
9.5.8.1. Middle East Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.5.8.2. Middle East Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.5.8.3. Middle East Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.5.8.4. Middle East Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
9.5.9. Africa
9.5.9.1. Africa Cannabidiol market size and forecast by Product Type, 2021-2031, (US$ million)
9.5.9.2. Africa Cannabidiol market size and forecast by Source Type, 2021-2031, (US$ million)
9.5.9.3. Africa Cannabidiol market size and forecast by Sales Type, 2021-2031, (US$ million)
9.5.9.4. Africa Cannabidiol market size and forecast by End-use, 2021-2031, (US$ million)
Chapter 10. Competitive Landscape
10.1. Market overview
10.2. Market share analysis/key player positioning
10.3. Developmental strategy benchmarking
10.3.1. New product development
10.3.2. Product launches
10.3.3. Business expansions
10.3.4. Partnerships, joint ventures, and collaborations
10.3.5. Mergers and acquisitions
Chapter 11. Company Profiles
11.1. Aurora Cannabis Inc. (Canada)
11.1.1. Company snapshot
11.1.2. Financial performance
11.1.3. Product offerings
11.1.4. Key strategic initiatives
11.1.5. SWOT analysis
11.2. Canopy Growth USA, LLC (U.S.)
11.2.1. Company snapshot
11.2.2. Financial performance
11.2.3. Product offerings
11.2.4. Key strategic initiatives
11.2.5. SWOT analysis
11.3. CV Sciences, Inc. (U.S.)
11.3.1. Company snapshot
11.3.2. Financial performance
11.3.3. Product offerings
11.3.4. Key strategic initiatives
11.3.5. SWOT analysis
11.4. Elixinol (U.S.)
11.4.1. Company snapshot
11.4.2. Financial performance
11.4.3. Product offerings
11.4.4. Key strategic initiatives
11.4.5. SWOT analysis
11.5. Endoca BV (Netherlands)
11.5.1. Company snapshot
11.5.2. Financial performance
11.5.3. Product offerings
11.5.4. Key strategic initiatives
11.5.5. SWOT analysis
11.6. Folium Biosciences (U.S.)
11.6.1. Company snapshot
11.6.2. Financial performance
11.6.3. Product offerings
11.6.4. Key strategic initiatives
11.6.5. SWOT analysis
11.7. Isodiol International Inc (U.S.)
11.7.1. Company snapshot
11.7.2. Financial performance
11.7.3. Product offerings
11.7.4. Key strategic initiatives
11.7.5. SWOT analysis
11.8. Medterra CBD, LLC (U.S.)
11.8.1. Company snapshot
11.8.2. Financial performance
11.8.3. Product offerings
11.8.4. Key strategic initiatives
11.8.5. SWOT analysis
11.9. NuLeaf Naturals, LLC (U.S.)
11.9.1. Company snapshot
11.9.2. Financial performance
11.9.3. Product offerings
11.9.4. Key strategic initiatives
11.9.5. SWOT analysis
11.10. PharmaHemp d.o.o. (Slovenia)
11.10.1. Company snapshot
11.10.2. Financial performance
11.10.3. Product offerings
11.10.4. Key strategic initiatives
11.10.5. SWOT analysis
*The List of Company Is Subject To Change During The Final Compilation of The Report
Key Players
- Aurora Cannabis Inc. (Canada)
- Canopy Growth USA, LLC (U.S.)
- CV Sciences, Inc. (U.S.)
- Elixinol (U.S.)
- Endoca BV (Netherlands)
- Folium Biosciences (U.S.)
- Isodiol International Inc (U.S.)
- Medterra CBD, LLC (U.S.)
- NuLeaf Naturals, LLC (U.S.)
- PharmaHemp d.o.o. (Slovenia)
Segmentation
By Product Type
- Oil
- Capsules
- Cream
- Suppositories
- Gum
- Others
By Source Type
- Marijuana
- Hemp
By Sales Type
- B2B
- B2C
By End-use
- Medical
-
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
-
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East
- Africa